Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium phenylbutyrate to enhance branched-chain amino acid oxidation in type 2 diabetes
NL-OMON28825Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium phenylbutyrate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Maastricht University. Primary endpoint: Change in whole-body insulin sensitivity. Started Jan 2019; status: active, not recruiting.
02
Drugs
sodium phenylbutyrate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON28825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28825.